Clinical Trial Update: Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing fidaxomicin to vancomycin for treatment of C. difficile-associated diarrhea has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Diarrhea

Drugs mentioned

• Dificid (fidaxomicin)
• Vancocin (vancomycin)

Snippet

Sponsor: Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Clostridium Infections, Diarrhea | Phase 3 | Status: COMPLETED | Results posted: 2011-10-26